News

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...
Makary’s FDA funding ask
FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...
FDA issues norovirus warning on frozen oysters from South Korea
The U.S. Food and Drug Administration is warning that certain half-shell oysters that are frozen and raw harvested in South ...
With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
FDA panel is split on updates to COVID shots as questions loom for fall vaccinations
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this ...
MedPage Today on MSN1d
FDA Chief Defends Job Cuts, COVID Booster Policy at Senate Hearing
Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
FDA Approves Nucala for Chronic Obstructive Pulmonary Disease
By Stephanie Brown HealthDay ReporterFRIDAY, May 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
US FDA advisers to weigh composition of COVID vaccines for 2025-2026
The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...
A Convenient Piece of Junk Science
RFK Jr. is prepared to rework the FDA’s official assessment of the abortion pill mifepristone based at least in part on a ...